JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
JP Morgan Upgrades VIVUS Inc. (VVUS) to Overweight
-
Unusual 11 Mid-Day Movers 07/16: LSBX, ARNA, AVII, CYPB, SCHW, TSLA Higher; VVUS, JST, ROIAK, OREX, PLCM Lower
-
Notable Analyst Rating Changes 07/16: GS, JPM, ARNA, ADM Upgraded; VVUS, BP, RBA, OREX Downgraded
-
Morning Movers 7/16: LSBX, ARNA, AVII Higher; VVUS, JST, VRNM, BIOF, VIDE, PLCM Lower
-
Arena Pharmaceuticals (ARNA) 17% Higher Following Vivus's Qnexa Blow-up
-
J.P. Morgan on Biotechnology and Drugs Stocks; Upgrades ARNA, Cuts VVUS
-
Wall Street Hubbub 7/15: JPMorgan's Earnings Quality "Weak", BP On Verge of Asset Sale, AIG's Benmosche Makes More Waves, iPhone 4 Fiasco
-
Morning Movers 7/13: ADCT, STXS, OREX, BRKS, VVUS, THLD, AETI Higher; AMED, CVLT, BPZ, BMTI Lower
-
Notable Analyst Rating Changes 07/08: PETD, NWL, LDK, SNBC Upgraded; NANO, HRB, BRK.A, DRWI Downgraded
-
Notable Analyst Rating Changes 04/27: PPDI, MRVL, TASR, CAVM Upgraded; AIG, HBAN, NWSA, ACN Downgraded
-
Notable Analyst Rating Changes 12/17: NWSA, UNM, LNC, PTV Upgraded; ADP, AEM, FGXI, OC Downgrades
-
After-Hours Movers 9/16: ARKR Higher; CKR, RIGL, VVUS, ORCL, EK, DBRN Lower
-
VIVUS (VVUS) to Offer 9M Common Shares
